AU2001230195A1 - Pharmaceutical compositions comprising terbinafine - Google Patents

Pharmaceutical compositions comprising terbinafine

Info

Publication number
AU2001230195A1
AU2001230195A1 AU2001230195A AU3019501A AU2001230195A1 AU 2001230195 A1 AU2001230195 A1 AU 2001230195A1 AU 2001230195 A AU2001230195 A AU 2001230195A AU 3019501 A AU3019501 A AU 3019501A AU 2001230195 A1 AU2001230195 A1 AU 2001230195A1
Authority
AU
Australia
Prior art keywords
terbinafine
pharmaceutical compositions
compositions
disintegrant
taste
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230195A
Other languages
English (en)
Inventor
Dieter Becker
Andreas Carl Eugster
Patrice Guitard
Stefan Hirsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2001230195A1 publication Critical patent/AU2001230195A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2001230195A 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine Abandoned AU2001230195A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0001315.1A GB0001315D0 (en) 2000-01-20 2000-01-20 Organic compounds
GB0001315 2000-01-20
PCT/EP2001/000562 WO2001052895A1 (en) 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine

Publications (1)

Publication Number Publication Date
AU2001230195A1 true AU2001230195A1 (en) 2001-07-31

Family

ID=9884039

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230195A Abandoned AU2001230195A1 (en) 2000-01-20 2001-01-18 Pharmaceutical compositions comprising terbinafine

Country Status (10)

Country Link
US (2) US20030017200A1 (enExample)
EP (1) EP1259261B1 (enExample)
JP (1) JP2003520252A (enExample)
AT (1) ATE297760T1 (enExample)
AU (1) AU2001230195A1 (enExample)
DE (1) DE60111503T2 (enExample)
ES (1) ES2241777T3 (enExample)
GB (1) GB0001315D0 (enExample)
PT (1) PT1259261E (enExample)
WO (1) WO2001052895A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
DE60124895D1 (de) * 2001-07-26 2007-01-11 Ethypharm Sa Umgehüllte Allylamine oder Benzylamine enthaltende Granulate, Verfahren zur Herstellung und in der Mundhöhle dispergierbare Tabletten enthaltend die umgehüllten Granulate
RU2214237C1 (ru) * 2002-04-24 2003-10-20 Закрытое акционерное общество "Брынцалов-А" Противогрибковое средство "брамизил"
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
CN110769830A (zh) 2017-05-12 2020-02-07 马瓦隆治疗有限公司 作为ii组代谢型谷氨酸受体的别构调节剂的取代的杂环化合物
CN110200929A (zh) * 2018-12-14 2019-09-06 悦康药业集团上海制药有限公司 一种含有盐酸特比萘芬的口服片及其制备方法
CN109674757A (zh) * 2019-02-22 2019-04-26 济南康和医药科技有限公司 一种盐酸特比萘芬组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
US4894592A (en) * 1988-05-23 1990-01-16 Fusion Systems Corporation Electrodeless lamp energized by microwave energy
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5661170A (en) * 1994-03-21 1997-08-26 Woodward Laboratories, Inc. Antimicrobial compositions and methods for using the same
GB9509631D0 (en) * 1995-05-12 1995-07-05 Sandoz Ltd Antifungal combination
GB9513750D0 (en) * 1995-07-06 1995-09-06 Sandoz Ltd Use of allylamines
EP1020193A4 (en) * 1997-09-30 2006-05-24 Daiichi Seiyaku Co ORAL PREPARATION
JP2000086503A (ja) * 1998-09-07 2000-03-28 Pola Chem Ind Inc 錠剤医薬組成物

Also Published As

Publication number Publication date
ES2241777T3 (es) 2005-11-01
ATE297760T1 (de) 2005-07-15
DE60111503T2 (de) 2006-05-18
US20100197804A1 (en) 2010-08-05
DE60111503D1 (de) 2005-07-21
EP1259261A1 (en) 2002-11-27
JP2003520252A (ja) 2003-07-02
US20030017200A1 (en) 2003-01-23
GB0001315D0 (en) 2000-03-08
EP1259261B1 (en) 2005-06-15
WO2001052895A1 (en) 2001-07-26
PT1259261E (pt) 2005-10-31

Similar Documents

Publication Publication Date Title
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
AP2005003318A0 (en) Pharmaceutical compositions comprising a basic respectively acidic drug coumpound, a surfactant and a physiologically tolerable watersoluble acid respectively base.
AU2001237525A1 (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
MXPA03007215A (es) Formulaciones farmaceuticas.
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
MXPA03004941A (es) Formulacion farmacologica que tiene tolerancia por via oral mejorada.
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
EP2311488A3 (en) Vaccine composition
GEP20074047B (en) Pramipexole once-daily dosage form
MXPA03006775A (es) Formulacion farmaceutica.
WO2001078680A3 (en) Pharmaceutical compositions comprising fluvastatin
WO2002100437A3 (en) Ophthalmic compositions comprising hyaluronic acid
AU2682401A (en) Flavonoid drug and dosage form, its production and use
BG108516A (en) Pharmaceutical formulation
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
MXPA03010761A (es) Combinaciones farmaceuticas.
EP1389203B8 (en) Analogs of thalidomide as angiogenesis inhibitors
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
BR0312728A (pt) Formulação em tablete dispersìvel e processo para sua preparação
GB0001315D0 (en) Organic compounds
AP2004003066A0 (en) Pharmaceutical compositions based on azetidine derivatives.
WO2003035686A3 (en) Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration